These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 79556)

  • 21. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
    Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
    Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of crystalloids and hydroxyethyl starch during normovolemic hemodilution. A study of hemodynamics and saturation measurement].
    Falchi S; Adembri C; Marinelli L; Tani R; Novelli GP
    Minerva Anestesiol; 1992 Apr; 58(4):145-9. PubMed ID: 1377806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
    Hausdörfer J; Hagemann H; Heine J
    Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
    Müller-Bühl U; Comberg HU; Diehm C; Allenberg J; Mörl H
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):241-3. PubMed ID: 6178019
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hydroxyethyl-derivative of starch--a new plasma substitute].
    Gryszkiewicz A
    Acta Haematol Pol; 1978; 9(2):137-42. PubMed ID: 78656
    [No Abstract]   [Full Text] [Related]  

  • 26. [Coagulation changes during aortofemoral bifurcation bypass: is volume and plasma substitution possible with hydroxyethyl starch alone?].
    von Sommoggy S; Fraunhofer J; Jelen-Esselborn S; Stemberger A
    Anaesthesist; 1990 Jul; 39(7):353-60. PubMed ID: 1696795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hydroxyethyl starch--an interim report].
    Weidhase R; Faude K; Weidhase R
    Anaesthesiol Reanim; 1998; 23(1):4-14. PubMed ID: 9553245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polish hydroxyethyl starch preparation: a clinical study].
    Schier J; Kościelak J; Szczepanik A; Gryszkiewicz A; Lopaciuk S; Konopka L; Rudowski W
    Acta Haematol Pol; 1979; 10(1):51-8. PubMed ID: 86269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
    Halmágyi M
    Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical experience and blood volume measurement following intravenous administration of hydroxyethylstarch 450/0.7 (author's transl)].
    Bergmann H; Necek S
    Wien Med Wochenschr; 1980 Jun; 130(11):367-9. PubMed ID: 6160681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxyethyl starch. Control of alpha-amylase hydrolysis and its subsequent clinical application.
    Mishler JM
    Acta Haematol Pol; 1980; 11(2):113-6. PubMed ID: 6158825
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of hydroxyethyl starch in blood transfusion and hematology].
    Fiala J
    Vnitr Lek; 1979 Sep; 25(9):897-902. PubMed ID: 91260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Volume substitution in acute normovolemic hemodilution. 5% human albumin vs. 6% hydroxyethyl starch].
    von Bormann B; Sticher J; Ratthey K; Idelberger R; Hempelmann G
    Infusionstherapie; 1990 Jun; 17(3):142-6. PubMed ID: 1697284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs.
    Yacobi A; Gibson TP; McEntegart CM; Hulse JD
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):199-204. PubMed ID: 6179136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Response to the comments on the contributions "Hypertonic solutions in heart surgery" and "Hypertonic hyperoncotic volume replacement (7.5 % NaCl/10 % hydroxyethyl starch 200,000/0.5) in patients with coronary artery stenoses" by H. Böhrer and E. Martin].
    Prien T
    Zentralbl Chir; 1993; 118(6):374. PubMed ID: 7688173
    [No Abstract]   [Full Text] [Related]  

  • 40. Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
    Caron A; Hacquard M; Audibert G; Cauchois G; Vigneron C; Stoltz JF; Longrois D; Menu P
    Clin Hemorheol Microcirc; 2006; 35(4):447-58. PubMed ID: 17148843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.